Anxiety and Depressive Symptoms and Cortical Amyloid-β Burden in Cognitively Unimpaired Older Adults - 21/11/24

Doi : 10.14283/jpad.2022.13 
Catriona K. Lewis 1, , O.M. Bernstein 2, J.D. Grill 3, 4, 5, D.L. Gillen 2, 3, D.L. Sultzer 3, 5
1 School of Medicine, University of California - Irvine, 1001 Health Sciences Rd, 92617, Irvine, CA, USA 
2 Department of Statistics, University of California - Irvine, Donald Bren School of Information and Computer Sciences, Irvine, USA 
3 Institute for Memory Impairments and Neurological Disorders (UCI MIND), University of California - Irvine, Irvine, USA 
4 Department of Neurobiology and Behavior, University of California - Irvine, School of Biological Sciences, Irvine, USA 
5 Department of Psychiatry and Human Behavior, University of California - Irvine, School of Medicine, Irvine, USA 

a lewisck@uci.edu lewisck@uci.edu

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Abstract

Background

There is evidence of relationships between behavioral symptoms and increased risk for Alzheimer’s Disease and/or Alzheimer’s Disease biomarkers. However, the nature of this relationship is currently unknown.

Objectives

To evaluate the relationship between anxiety and depressive symptoms and amyloid-β deposition in cognitively unimpaired older adults, and to assess mediating effects of either objective or subjective cognitive skills.

Design

Cross-sectional analysis of screening data from participants enrolled in the Anti-Amyloid Treatment in Asymptomatic Alzheimer Disease (A4) Study (ClinicalTrials.gov Identifier: NCT02008357)

Setting

Data analysis

Participants

4492 cognitively unimpaired adults, age 65–85, enrolled in the Anti-Amyloid Treatment in Asymptomatic Alzheimer Disease (A4) Study

Measurements

We used linear regression to estimate the associations between amyloid-β standard uptake value ratio (SUVR) and Geriatric Depression Scale (GDS) and State Trait Anxiety Inventory (STAI) scores while adjusting for potential confounding factors as well as for Cognitive Function Index (CFI) or Preclinical Alzheimer’s Cognitive Composite (PACC) scores as possible mediational variables.

Results

4399 subjects with complete covariates were included (mean age: 71.3, 59% female), GDS ranged 0–13 (mean: 1.0), and STAI ranged 6–24 (mean: 9.9). Amyloid-β SUVR was modestly associated with STAI; mean STAI score was estimated to be 0.275 points higher (95% CI: 0.038, 0.526; p-value = 0.023) for each 0.5-point increase in cortical amyloid-β SUVR. Subjective cognitive decline (CFI) attenuated the relationship between SUVR and STAI, while objective cognitive function (PACC) did not. No statistically significant relationship between SUVR and GDS was observed (p = 0.326).

Conclusions

In cognitively unimpaired adults with low levels of depression and anxiety, cortical amyloid-β deposition is associated with anxiety but not depressive symptoms. Attenuation of this relationship by subjective cognitive difficulties suggests that anxiety may be partly due to such a perception resulting from cortical amyloid-β deposition.

Il testo completo di questo articolo è disponibile in PDF.

Key words : Amyloid-β, depression, anxiety


Mappa


© 2022  THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 9 - N° 2

P. 286-296 - Aprile 2022 Ritorno al numero
Articolo precedente Articolo precedente
  • Alzheimer’s Disease Prevention Health Coaching
  • Annie Rhodes, J. Inker, J. Richardson, F. Zanjani
| Articolo seguente Articolo seguente
  • Dual Task Performance Is Associated with Amyloidosis in Cognitively Healthy Adults
  • Jason K. Longhurst, J.L. Cummings, S.E. John, B. Poston, J.V. Rider, A.M. Salazar, V.R. Mishra, A. Ritter, J.Z. Caldwell, J.B. Miller, J.W. Kinney, M.R. Landers

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.